Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[New challenges in multiple sclerosis treatment].
Differential Regulation of CD4+ T Cell Adhesion to Cerebral Microvascular Endothelium by the β-Chemokines CCL2 and CCL3.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis.
Ureteral rupture from aberrant Foley catheter placement: A case report.
Mediation of Protection and Recovery From Experimental Autoimmune Encephalomyelitis by Macrophages Expressing the Human Voltage-Gated Sodium Channel NaV1.5.
Multiple sclerosis in children.
Month of birth is not a definite risk factor for multiple sclerosis.
Pathologic role of glial nitric oxide in adult and pediatric neuroinflammatory diseases.
Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome Susceptibility.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
Association between retinal nerve fiber layer thickness and magnetic resonance imaging findings and intelligence in patients with multiple sclerosis.
Comprehensive Profile of Cardiopulmonary Exercise Testing in Ambulatory Persons with Multiple Sclerosis.
[Fampridine and multiple sclerosis.]
Treatment of acute optic neuritis and vision complaints in multiple sclerosis.
Novartis provides update on fingolimod Phase III trial in primary progressive MS (PPMS)
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
Simultaneous Determination of Oxysterols, Cholesterol and 25-Hydroxy-Vitamin D3 in Human Plasma by LC-UV-MS.
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis.
Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions.
Non-protein amino acids and neurodegeneration: The enemy within.
Processes of plasma protein N-homocysteinylation in multiple sclerosis.

Pages